维普中文期刊产品整合服务
58篇 您的检索式:作者名="RUSCONI P"
    题名 作者 年代 出处 被引量
1Inhibition of rat cornealangiogenesis by a nuclease resistant RNA aptamer specific for angiopoietin-2显示文摘White R R Shan S Rusconi C P 2003Proc Natl Acad Sci USA2003,100,9:1
2Serial measurements of serum NTproBNP as markers of left ventricular systolic function and remodeling in children with heart failure显示文摘RUSCONI P LUDWIG D A RATNASAMY C 2010Am Heart J2010,160,4:1
3Seri-almeasurements of serum NT-proBNP as markers of left ventricu-larfunction and remodeling in children with heart failure显示文摘RUSCONI P G LUDWIG D A RATNASAMY C 2010Am Heart J2010,160,4:1
4RNA aptamers as reversible antagonists of coagulation factor Ⅸa 显示文摘 2002Nature2002,419,5:1
5Developing aptamers into therapeutics显示文摘WHITE R R SULLENGER B A RUSCONI C P 2000J Clin Invest2000,106,:1
6Differential diappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes 显示文摘Costa P Rusconi S Mingari MC 2001AIDS2001,15,8:1
7Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes显示文摘Costa P Rusconi S Fogli M 2003AIDS2003,17,2:1
8Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection:in vitro studies of mixed virus infections显示文摘Rusconi S La Seta Catamancio S Citterio P 2000J Virol2000,74,19:1
9Aptamers: an emerging class of therapeutics显示文摘Nimjee S M Rusconi C P Sullenger B A 2005Annu Rev Med2005,56,:1
10progression of valvular aortic stenosis in adults: literature review and clinical implication显示文摘Faggiano P Aurigemma GP Rusconi C 1996Am Heart J1996,132,21:1
11Developing aptamers into therapeutics显示文摘White R R Sullenger B A Rusconi C P 2000J Clin Invest2000,106,8:1
12RNA aptamers as reversible antagonists of coagulation factor IXa 显示文摘Rusconi C P Scardino E Layzer J 2002Nature2002,419,6902:1
13Naphthalene sulfonate polymers with CD4- blocking and anti-human immunodeficiency virus type 1 activities显示文摘Rusconi S Moonis M Merrill D P et at 1996Antimicrob Agents Chemother1996,40,1:1
14A randomized, repeat-dose, pharmacodynamic and safety study of an antidote- controlled factor IXa inhibitor 显示文摘Chan M Y Rusconi C P Alexander J H 2008J Thromb Haemost2008,6,5:1
15Carvedilol in children with cardiomyopathy: 3 year experience at a single institution显示文摘Rusconi P Gomez MO Rossique GM 2004J Heart Lung Transplant2004,23,7:1
16Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the second international conference on pediatric cardiomyopathy显示文摘Kantor PF Rusconi P Lipshultz S 2011Prog Pediatr Cardiol2011,32,1:1
17Erythroid differentiation and maturation from peripheral CD34 + cells in liquid cuhure:cel-lular and molecular characterization 显示文摘Ronzoni L Bonara P Rusconi D 2008Blood Cells Mol Dis2008,40,2:1
18Biomarkers in pediatric heart failure:Their role in diagnosis and evaluating disease progression显示文摘Kantor PF Rusconi P 0,,01:1
19What we know and would like to know about CDKL5 and its involvement in epi- leptic encephalopathy显示文摘Fdlstmp-Nielsen C Rusconi L La Montanara P 2012Neural Plast2012,2012,72:1
20Aptamers:an emersing class of therapeutics显示文摘Nimjee S M Rusconi C P Sullenger B A 2005Annu Rev Med2005,56,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费